SNCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient entry. SNCR is technically in an uptrend (bullish moving averages) but is extended into nearby resistance (8.88–8.95) while momentum is fading (MACD histogram still negative). With no Intellectia buy signals today and fundamentals/analyst targets pointing to challenged growth, the risk-reward for buying immediately is not attractive; better to wait for either a clean breakout above ~8.95 or a pullback toward support (8.64–8.57).
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the intermediate trend is up. Momentum: MACD histogram = -0.0643 (below zero) but contracting—bearish momentum is weakening, yet not flipped to bullish. RSI: RSI_6 = 67, near the upper end of neutral (approaching overbought), implying limited immediate upside without consolidation. Levels: Pivot 8.761. Price 8.83 is above pivot and pressing resistance R1 8.879 and R2 8.953; supports at S1 8.643 and S2 8.569. Near-term pattern stats: similar-pattern read shows ~80% chance of -0.43% next day, +1.23% next week, +6.31% next month—mildly bullish beyond the very short term but with near-term churn risk.
Intellectia Proprietary Trading Signals
Technical uptrend remains intact (bullish MA stack), so a breakout above ~8.95 could trigger momentum buying.
Options market is strongly call-skewed with outsized volume, often accompanying bullish positioning.
Analyst still maintains a Buy rating (Roth), implying some institutional support for the longer-term thesis.
No notable insider selling trend reported recently (insiders neutral).
while RSI is elevated and MACD is still below zero—setup favors consolidation/pullback over immediate upside.
Latest quarter: 2025/Q3. Revenue: $42.00M, down -2.24% YoY (continued top-line pressure). Net income: $5.81M, down -201.96% YoY. EPS: $0.51, down -191.07% YoY. Gross margin: 68.76%, down -0.20% YoY (roughly stable, but not expanding). Overall: Margins are holding relatively steady, but growth is weak and YoY profit/EPS comparisons are unfavorable, aligning with commentary about challenged growth.
Recent trend: Roth Capital kept a Buy rating but lowered its price target to $10 from $13 (2025-11-05/06) citing modest revenue miss and still challenged growth, despite EBITDA remaining relatively defended. Wall Street-style pros: streamlined operations/defended EBITDA; still rated Buy by the covering analyst; potential upside to the $10 target (~13% from $8.83). Cons: repeated price-target cut indicates reduced confidence in growth/trajectory; revenue softness persists; the buy case leans more on cost discipline than accelerating demand. Politicians/congress: No recent congress trading data available; no meaningful politician activity indicated.
